Use of a novel configuration of ports for patients needing intermittent long-term apheresis.
Matthew S HowlettKimani HicksYara A ParkMatthew S KarafinPeter R BreamPublished in: Journal of clinical apheresis (2024)
The introduction of a novel device configuration of venous access ports for intermittent apheresis resulted in higher flow rates and less total time for treatment. Use of tPA was greatly reduced. These results suggest that the new configuration could result in less expense for the hospital and better throughput in a busy pheresis practice. Clinical trial registration with ClinicalTrials.gov: NCT04846374.
Keyphrases
- clinical trial
- healthcare
- end stage renal disease
- newly diagnosed
- ejection fraction
- primary care
- high intensity
- prognostic factors
- emergency department
- randomized controlled trial
- quality improvement
- study protocol
- patient reported outcomes
- double blind
- electronic health record
- replacement therapy
- combination therapy